Releases
ODTC
22005.00
0.00%
--
  • All
  • Financials
  • Insiders
More
Webull provides the latest Odonate, Inc. (ODTC) stock and general news. This information may help you make smarter investment decisions.
About ODTC
Odonate, Inc., formerly Odonate Therapeutics, Inc., is a pharmaceutical company. The Company is focused on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The Company is no longer in development of tesetax.